BCAB vs ECL
Bioatla Inc (BCAB) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
BCAB currently screens at market cap $5.9M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the BCAB and ECL stock pages for the full models.
Not investment advice.